CAS 121679-20-7

N-methyl-2-[3-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-1H-indol-5-yl]ethanesulfonamide

Description:

N-methyl-2-[3-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-1H-indol-5-yl]ethanesulfonamide, with CAS number 121679-20-7, is a chemical compound characterized by its complex structure, which includes an indole moiety and a pyridine ring. This compound is typically classified as a sulfonamide due to the presence of the sulfonamide functional group (-SO2NH-), which contributes to its potential biological activity. The presence of the methyl group on the nitrogen atom and the ethyl sulfonamide group suggests that it may exhibit specific interactions with biological targets, possibly influencing its pharmacological properties. The compound's molecular structure indicates potential for lipophilicity, which can affect its solubility and permeability in biological systems. Additionally, the presence of multiple heteroatoms and aromatic systems may contribute to its reactivity and stability under various conditions. Overall, this compound may be of interest in medicinal chemistry, particularly in the development of therapeutic agents targeting specific biological pathways.

Formula: C₁₇H₂₃N₃O₂S

InChI: InChI=1/C17H23N3O2S/c1-18-23(21,22)10-7-13-3-4-17-15(11-13)16(12-19-17)14-5-8-20(2)9-6-14/h3-5,11-12,18-19H,6-10H2,1-2H3

SMILES: CNS(=O)(=O)CCc1ccc2c(c1)c(c[nH]2)C1=CCN(C)CC1

3,4-dihydro Naratriptan

CAS: 121679-20-7

Formula: C₁₇H₂₃N₃O₂S

Color and Shape: Solid

Molecular weight: 333.4484

Ref: IN-DA0015K0

Naratriptan Impurity 1

CAS: 121679-20-7

Formula: C₁₇H₂₃N₃O₂S

Molecular weight: 333.45

Ref: 4Z-N-2711

Naratriptan USP Related Compound B

CAS: 121679-20-7

Formula: C₁₇H₂₃N₃O₂S

Molecular weight: 333.45

Ref: ST-EA-CP-N4007

3,4-Didehydro Naratriptan (Naratriptan Impurity B)

Controlled Product

CAS: 121679-20-7

Applications Naratriptan related compound B. Naratriptan impurity B.

Formula: C₁₇H₂₃N₃O₂S

Color and Shape: Neat

Molecular weight: 333.45

Ref: TR-D449205

3,4-Dihydro naratriptan

CAS: 121679-20-7

3,4-Dihydro naratriptan is a medicinal compound that is used as an anti-migraine drug. It is a hydrogenated form of the parent molecule naratriptan and has been shown to have a reaction time of about 30 minutes when catalyzed by palladium. The impurity, 3,4-dihydro naratriptan sulfonamide, has been found to be less potent than the target compound and can be eliminated from the synthesis by using catalytic hydrogenation. 3,4-Dihydro naratriptan sulfonamide can also be reduced by catalytic hydrogenation to yield 3,4-dihydro naratriptan.

Formula: C₁₇H₂₃N₃O₂S

Purity: Min. 95%

Molecular weight: 333.45 g/mol

Ref: 3D-ID21930